| |
| |
|
| Insider
Information: |
Yanchik Connealy Pamela |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,172,406 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$70,654 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,172,406 |
|
|
| Total
Value |
$70,654 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunovant Inc |
IMVT |
Chief Financial Officer |
2021-03-19 |
46,200 |
2021-03-19 |
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
|
2024-03-26 |
1,110,293 |
2022-03-31 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-07-20 |
15,913 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PYXS |
Pyxis Oncology, Inc. |
CFO & COO |
• – – |
2024-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
328,710 |
1,110,293 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-11-29 |
4 |
D |
$1.40 |
$51,729 |
D/D |
(36,949) |
781,583 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-09-28 |
4 |
B |
$1.87 |
$14,960 |
D/D |
8,000 |
818,532 |
2.74 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-09-27 |
4 |
B |
$1.85 |
$11,868 |
D/D |
6,426 |
810,532 |
2.74 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-09-25 |
4 |
B |
$1.67 |
$20,044 |
D/D |
12,000 |
804,106 |
2.74 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-09-22 |
4 |
B |
$1.74 |
$8,695 |
D/D |
5,000 |
792,106 |
2.74 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
187,793 |
782,106 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2023-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,667 |
15,913 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2023-04-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
758 |
4,246 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
CFO and COO |
• – – |
2023-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
209,803 |
594,313 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,488 |
3,488 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
43,493 |
384,510 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Chief Financial Officer |
• • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
247,524 |
247,524 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
46,200 |
46,200 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
